BioTrove, Inc. today announced the launch of Pathways pre-validated qPCR assay panels, the latest addition to the OpenArray(TM) Real-Time qPCR System. These standardized panels contain a pre-determined set of optimized, validated assays, allowing researchers to skip the initial steps of gene selection and assay optimization, and begin immediate work on the analyses of commonly studied gene families involved in disease states and biochemical pathways.

“Insight into the regulation of gene expression is essential to understanding cellular function and structure in cells or tissues – both normal and diseased. Our Pathways panels, pre-validated in our laboratories, are a ‘ready-to-use,’ time-saving addition to our OpenArray product family,” said Kevin Munnelly, Vice President and General Manager of OpenArray. “These panels are designed and optimized to allow our customers to focus more on furthering genomic exploration, whether used in the discovery or validation of biologically relevant genes.”

Designed for thermal-cycling and imaging in the OpenArray NT Cycler, the new Pathways pre-validated assay panels provide customers with a defined set of biologically-relevant assays which correspond to specific research areas, including ADME, apoptosis, cancer, cardiovascular disease, inflammation, kinome and signal transduction. Using the OpenArray Pathways platform, researchers can screen up to four samples against more than 600 genes on a single plate.

“BioTrove is committed to advancing screening and discovery in life science research using systems biology approaches – and the newest member of our OpenArray family does just that,” said Albert A. Luderer, Ph.D., President and CEO, BioTrove. “Pathways pre-validated assay panels will simplify the analysis of biochemical pathways and disease genes, helping to advance the genomic research that impacts healthcare, biomedical research and much more.”

Additional assays are currently under development. For more information on the OpenArray Pathways system, please visit BioTrove at the Multiplexed Genomics Tools: qPCR and Microarrays conference from September 21-23 in Providence, Rhode Island at Booth #1. More information is also available at www.biotrove.com/pathways.